OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
Isaline Mees, Rebecca M. Nisbet, Anthony J. Hannan, et al.
Journal of Huntington s Disease (2023) Vol. 12, Iss. 1, pp. 1-13
Open Access | Times Cited: 12
Isaline Mees, Rebecca M. Nisbet, Anthony J. Hannan, et al.
Journal of Huntington s Disease (2023) Vol. 12, Iss. 1, pp. 1-13
Open Access | Times Cited: 12
Showing 12 citing articles:
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review
J Yang, Weijia Zhi, Lifeng Wang
Molecules (2024) Vol. 29, Iss. 12, pp. 2812-2812
Open Access | Times Cited: 13
J Yang, Weijia Zhi, Lifeng Wang
Molecules (2024) Vol. 29, Iss. 12, pp. 2812-2812
Open Access | Times Cited: 13
Mild cognitive impairment in Huntington’s disease: challenges and outlooks
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 4, pp. 289-304
Closed Access | Times Cited: 5
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 4, pp. 289-304
Closed Access | Times Cited: 5
Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
Sergio Pérez‐Oliveira, Juan Castilla‐Silgado, Cèlia Painous, et al.
Brain Pathology (2024) Vol. 34, Iss. 4
Open Access | Times Cited: 4
Sergio Pérez‐Oliveira, Juan Castilla‐Silgado, Cèlia Painous, et al.
Brain Pathology (2024) Vol. 34, Iss. 4
Open Access | Times Cited: 4
Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Rare Diseases, Spotlighting Amyotrophic Lateral Sclerosis, Huntington’s Disease, and Myasthenia Gravis: Insights from Landscape Analysis of Current Research
Kavita A. Iyer, Rumiana Koynova, Janet M. Sasso, et al.
Biochemistry (2025)
Closed Access
Kavita A. Iyer, Rumiana Koynova, Janet M. Sasso, et al.
Biochemistry (2025)
Closed Access
Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data
Yun Su Hwang, Eungseok Oh, Manho Kim, et al.
Journal of the Neurological Sciences (2023) Vol. 452, pp. 120744-120744
Closed Access | Times Cited: 7
Yun Su Hwang, Eungseok Oh, Manho Kim, et al.
Journal of the Neurological Sciences (2023) Vol. 452, pp. 120744-120744
Closed Access | Times Cited: 7
Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing
V.S. Makeeva, Nadezhda S. Dyrkheeva, Olga I. Lavrik, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16798-16798
Open Access | Times Cited: 5
V.S. Makeeva, Nadezhda S. Dyrkheeva, Olga I. Lavrik, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16798-16798
Open Access | Times Cited: 5
Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Víctor Cuevas-Espinoza, et al.
Ageing Research Reviews (2024), pp. 102594-102594
Closed Access | Times Cited: 1
Margrethe A. Olesen, Francisca Villavicencio-Tejo, Víctor Cuevas-Espinoza, et al.
Ageing Research Reviews (2024), pp. 102594-102594
Closed Access | Times Cited: 1
The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases
Danton H. O’Day
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13424-13424
Open Access | Times Cited: 1
Danton H. O’Day
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13424-13424
Open Access | Times Cited: 1
Examples of diseases where appropriate therapies were discovered
Moyra Smith
Elsevier eBooks (2024), pp. 209-262
Closed Access
Moyra Smith
Elsevier eBooks (2024), pp. 209-262
Closed Access
Therapies that address altered gene regulation
Moyra Smith
Elsevier eBooks (2024), pp. 263-292
Closed Access
Moyra Smith
Elsevier eBooks (2024), pp. 263-292
Closed Access
